News & Updates
Showing Multidisciplinary articles
Showing

HK-Chinese model predicts 10-year ASCVD risk in patients with schizophrenia-spectrum disorders
A Hong Kong–Chinese (HK-Chinese) model achieves satisfactory accuracy in predicting 10-year atherosclerotic cardiovascular disease (ASCVD) risk in Chinese patients with schizophrenia-spectrum disorders, according to a population-based cohort study.
HK-Chinese model predicts 10-year ASCVD risk in patients with schizophrenia-spectrum disorders
10 Apr 2026
Finerenone protects kidneys in patients with T1D + CKD
Finerenone significantly reduces albuminuria vs placebo and maintains a manageable safety profile in patients with type 1 diabetes (T1D) and chronic kidney disease (CKD) receiving background therapy with renin-angiotensin-aldosterone system inhibitors (RAASi), the phase III FINE-ONE trial has shown. These findings represent an important step forward since RAASi were introduced for renoprotection in T1D more than 30 years ago.
Finerenone protects kidneys in patients with T1D + CKD
09 Apr 2026
Is red meat a risk factor for MASLD?
High consumption of red meat appears to increase the incidence of metabolic dysfunction-associated steatotic liver disease (MASLD), but only in men, particularly at intake levels ranging from 75 to 90 g/day, reveals a recent study.






